Global CRO Icon has appointed professor Brendan Buckley chief medical officer. Professor Buckley will be Icon’s lead medical expert, representing the company’s position on scientific, ethical and medical governance matters and provide guidance and oversight to the medical and scientific groups across Icon.

An endocrinologist with over 30 years’ experience, Brendan joined Icon through the acquisition of Firecrest Clinical in 2011, where he was one of the company’s founders and senior vice president of Medical Affairs. 

Brendan has extensive experience in trials and chairs several independent Data and Safety Monitoring Boards for medium to large cardio-metabolic and rare disease clinical studies. Brendan is clinical professor of Medicine and Pharmacology at the School of Medicine, University College Cork (UCC), Ireland, and also has been director of the university’s European Center for Clinical Trials in Rare Diseases.

He has been a board member of the Irish Medicines Board and the EMA’s Scientific Advisory Group for Diabetes and Endocrinology since 2005. He also was a member of the EMA Committee for Orphan Medicinal Products from 2000 to 2003 and a member of the EMA’s panel of experts. Professor Buckley also is chairman of the Irish Statutory Anti-Doping Agency and is a member of the U.K. Anti-Doping Scientific Advisory Board.